, CONTAINS FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE SECURITIES ACT OF 1933, AS AMENDED (the SECURITIES ACT), AND SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (the EXCHANGE ACT), that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements may refer to such m...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-10 | 2025-12-31 | 0001493152-26-009411 | EDGAR | 69K words |
| 2025-03-13 | 2024-12-31 | 0001493152-25-010146 | EDGAR | — |
| 2024-03-07 | 2023-12-31 | 0001493152-24-009127 | EDGAR | — |
| 2023-03-10 | 2022-12-31 | 0001493152-23-007178 | EDGAR | — |
| 2022-03-09 | 2021-12-31 | 0001493152-22-006353 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001104659-21-034761 | EDGAR | — |
| 2020-03-13 | 2019-12-31 | 0001104659-20-032764 | EDGAR | — |
| 2019-03-06 | 2018-12-31 | 0001144204-19-012434 | EDGAR | — |
| 2018-03-12 | 2017-12-31 | 0001144204-18-013981 | EDGAR | — |
| 2017-03-06 | 2016-12-31 | 0001144204-17-012930 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001493152-25-021007 | EDGAR | 32K words |
| 2025-08-05 | 2025-06-30 | 0001493152-25-011588 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001641172-25-009180 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001493152-24-043893 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001493152-24-030648 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001493152-24-018311 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001493152-23-039861 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001493152-23-027460 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001493152-23-016293 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001493152-22-031032 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001493152-22-021567 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0001493152-22-012445 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-02 | 0001493152-26-014835 | EDGAR | 1K words |
| 2026-04-02 | 0001493152-26-014834 | EDGAR | — |
| 2026-03-10 | 0001493152-26-009428 | EDGAR | — |
| 2026-03-04 | 0001493152-26-008852 | EDGAR | — |
| 2026-02-18 | 0001493152-26-007288 | EDGAR | — |
| 2026-02-18 | 0001493152-26-007287 | EDGAR | — |
| 2026-01-20 | 0001493152-26-002785 | EDGAR | — |
| 2026-01-12 | 0001493152-26-001864 | EDGAR | — |
| 2026-01-12 | 0001493152-26-001254 | EDGAR | — |
| 2025-12-16 | 0001493152-25-027914 | EDGAR | — |
516 total filings indexed. 484 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001535955 |
| Ticker | LPCN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.lipocine.com |
| Listed | 2012-06-05 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report